BNGO

Companies
NASDAQ
Bionano Genomics Inc.
Health Care
Price Chart
Overview

About BNGO

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Market Cap
$59.9M
Volume
671.7K
Avg. Volume
669.0K
P/E Ratio
-7.693877
Dividend Yield
0.00%
Employees
328.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Instruments & Supplies
Risk & Correlation Analysis
Market Correlation
1.76
High Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
High Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BNGO.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BNGO shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$59.9M
Volume671.7K
P/E Ratio-7.69
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 6, 2025

PortfolioPilot Analysis

Get AI-powered insights on how BNGO fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025